Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, and efficacy of odanacatib (MK-0822) in postmenopausal women previously treated with a bisphosphonate for osteopor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• odanacatib (odanacatib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-18